每经AI快讯，中控技术（SH 688777，收盘价：46.87元）12月18日晚间发布公告称，公司审议通过了 《关于聘任副总裁的议案》《关于聘任财务负责人的议案》《关于聘任董事会秘书的议案》。经公司总 裁提名并经董事会提名委员会及审计委员会审核，公司董事会同意聘任余晶鑫先生、陆伟民先生为公司 副总裁，同意聘任孙华丰先生担任公司财务负责人，同意聘任杨振华先生担任公司董事会秘书。 每经头条（nbdtoutiao）——海南封关政策红利全解析：零关税、低个税、投资准入放宽、跨境资金自 由、创业扶持…… （记者 曾健辉） 2024年1至12月份，中控技术的营业收入构成为：化工占比36.83%，石化占比20.28%，油气占比 9.68%，制药食品占比8.11%，能源占比5.85%，其他占比5.79%，冶金占比5.34%。 截至发稿，中控技术市值为371亿元。 ...

Group 1 - The company Zhongkong Technology (SH 688777) announced a share buyback of approximately 200,000 shares, representing 0.0248% of its total share capital of about 791 million shares, with a total transaction amount of approximately 10 million yuan [1][1][1] - The highest buyback price was 51 yuan per share, while the lowest was 50.77 yuan per share [1][1][1] - As of the report, Zhongkong Technology has a market capitalization of 40.2 billion yuan [1][1][1] Group 2 - In 2024, the revenue composition of Zhongkong Technology is as follows: Chemicals 36.83%, Petrochemicals 20.28%, Oil and Gas 9.68%, Pharmaceuticals and Food 8.11%, Energy 5.85%, Others 5.79%, and Metallurgy 5.34% [1][1][1]

Core Viewpoint - Zhongkong Technology (688777.SH) announced its first share repurchase on November 4, 2025, through the Shanghai Stock Exchange, indicating a strategic move to enhance shareholder value [1] Summary by Categories Share Repurchase Details - The company repurchased a total of 196,400 shares, which represents 0.0248% of its total share capital [1] - The highest price for the repurchased shares was 51.00 CNY per share, while the lowest price was 50.77 CNY per share [1] - The total amount spent on the repurchase was 10 million CNY, excluding transaction commissions and other fees [1]

Core Viewpoint - Zhongkong Technology (688777.SH) reported a decline in both revenue and net profit for the third quarter, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved a revenue of 1.824 billion yuan in the third quarter, representing a year-on-year decrease of 12.52% [1] - The net profit attributable to shareholders was 77.53 million yuan, down 61.25% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 49.57 million yuan, reflecting a significant decline of 72.91% year-on-year [1] - The basic earnings per share stood at 0.10 yuan [1]

Group 1 - The core point of the article is that Zhongkong Technology (SH 688777) held its 15th meeting of the 6th board of directors on October 24, 2025, to review the proposal for the third quarter report of 2025 [1] - For the year 2024, the revenue composition of Zhongkong Technology is as follows: Chemicals 36.83%, Petrochemicals 20.28%, Oil and Gas 9.68%, Pharmaceuticals and Food 8.11%, Energy 5.85%, Others 5.79%, and Metallurgy 5.34% [1] - As of the time of reporting, Zhongkong Technology has a market capitalization of 42 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have generated 80 billion USD in overseas licensing this year, indicating a strong performance in the biopharmaceutical sector [1] - There is a discussion on the hot secondary market for biomedicine, while the primary market is experiencing a cooling in fundraising, highlighting a divergence in market conditions [1]

Company Summary - Zhongkong Technology announced a credit impairment loss of 91.79 million yuan and an asset impairment loss of 20.83 million yuan for the first half of 2025, totaling approximately 113 million yuan [1] - The impairment provisions will impact the company's consolidated profit for the first half of 2025 by about 113 million yuan [1] - The reported figures are unaudited and subject to final confirmation by the accounting firm [1] Revenue Composition - For the year 2024, Zhongkong Technology's revenue composition is as follows: Chemicals 36.83%, Petrochemicals 20.28%, Oil and Gas 9.68%, Pharmaceuticals and Food 8.11%, Energy 5.85%, Others 5.79%, and Metallurgy 5.34% [1] Market Capitalization - As of the report, Zhongkong Technology has a market capitalization of 41.1 billion yuan [1]

Group 1 - Zhongkong Technology Co., Ltd. has successfully won two major upgrade projects from China Petroleum & Chemical Corporation (Sinopec) for the Maoming Petrochemical 1 million tons ethylene (DCS/SIS/GDS) and Henan Refining 1 million tons ethylene (DCS) projects [1] - To date, Zhongkong Technology has undertaken a total of 28 large-scale ethylene projects [1]

Core Viewpoint - The company is actively monitoring opportunities in the hydropower sector, particularly in relation to a significant investment of 1.2 trillion in hydropower projects by the government [1] Group 1 - The company has previously participated in multiple national hydropower projects [1] - The company emphasizes its commitment to closely follow policy developments and project progress in the hydropower industry [1] - The company will conduct tracking based on industry conditions and its own situation [1]

Core Points - The announcement details the third vesting period of the 2021 Restricted Stock Incentive Plan of Zhongkong Technology Co., Ltd, with 598,271 shares to be listed for trading on August 4, 2025 [2][3][15] - The decision-making process for the vesting of the restricted stock involved multiple board meetings and approvals, ensuring compliance with regulations and independent opinions [4][5][6][9][11] Summary by Sections Vesting Details - The total number of shares for this vesting period is 598,271 [3][21] - The shares will be listed for trading on August 4, 2025 [4][15] Decision-Making Process - The board of directors approved the incentive plan on December 15, 2021, and the independent directors provided opinions on its benefits [4][5] - The plan was publicly disclosed and underwent a review process with no objections raised during the internal announcement period [6][7] Stock Source and Impact - The shares are sourced from the company's issuance of A-share common stock to the incentive targets [14] - The number of incentive recipients is 793, and the vesting does not involve any company directors or senior management [15][16] Financial Impact - The company reported a net profit of approximately 120 million yuan for Q1 2025, with the new shares representing about 0.0757% of the total share capital, indicating a minimal impact on earnings per share [19]